1-(2-Chloroethyl)-4-[4-(2-chloroethyl)phenyl]sulfonylbenzene | 92969-32-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(2-Chloroethyl)-4-[4-(2-chloroethyl)phenyl]sulfonylbenzene
• CAS: 92969-32-9
• 化学式: C₁₆H₁₆Cl₂O₂S
• 分子量: 343.274
• InChiKey: OIMXBRVTWPROPJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  21
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  42.5
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• PROCESS FOR PREPARATION OF ELETRIPTAN AND SALT THEREOF
  申请人：Sathe Dhananjay Govind

  公开号：US20120071669A1

  公开（公告）日：2012-03-22

  The present invention relates to an improved process for the preparation of 3-(N-methyl-2(R)-pyrrolidinyl methyl)-5-[2-(phenyl sulfonyl)ethyl]-1H-indole or pharmaceutically acceptable salts thereof, particularly 3-(N-methyl-2(R)-pyrrolidinyl methyl)-5-[2-(phenyl sulfonyl)ethyl]-1H-indole hydrobromide (Eletriptan hydrobromide). The present invention further relates to novel polymorphs of 3-(N-methyl-2(R)-pyrrolidinyl methyl)-5-[2-(phenyl sulfonyl)ethenyl]-1H-indole hydrobromide and process for preparation thereof.

  本发明涉及一种改进的制备3-(N-甲基-2(R)-吡咯烷基)-5-[2-(苯基磺酰基)乙基]-1H-吲哚或其药学上可接受的盐，特别是3-(N-甲基-2(R)-吡咯烷基)-5-[2-(苯基磺酰基)乙基]-1H-吲哚溴化氢盐（依那曲坦溴化氢盐）。本发明还涉及3-(N-甲基-2(R)-吡咯烷基)-5-[2-(苯基磺酰基)乙烯基]-1H-吲哚溴化氢盐的新晶型及其制备方法。
• Pyrrolidine Derivatives as Histamine H3 Receptor Antagonists
  申请人：Beavers Lisa Selsam

  公开号：US20080207732A1

  公开（公告）日：2008-08-28

  The present invention discloses novel compounds of Formula (I) or pharmaceutically acceptable salts thereof which have histamine-H3 receptor antagonist or inverse agonist activity, as well as methods and intermediates for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using them to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases.

  本发明披露了公式（I）的新化合物或其药学上可接受的盐，具有组胺-H3受体拮抗剂或反向激动剂活性，以及制备这些化合物的方法和中间体。在另一种实施方式中，本发明披露了包含公式（I）化合物的药物组合物，以及使用它们治疗肥胖、认知障碍、嗜睡症和其他组胺H3受体相关疾病的方法。
• N-(arylthioalkyl)-N'-(aminoalkyl)ureas
  申请人：A.H. ROBINS COMPANY, INCORPORATED

  公开号：EP0066415A2

  公开（公告）日：1982-12-08

  N-(Arylthioalkyl)-N'-(aminoalkyl)ureas and thioureas and oxidation derivatives having the formula wherein B represents a thio, sulphinyl or sulphonyl group; R1 and R2 each represent a hydrogen atom or a loweralkyl, cycloalkyl, 2-furanyl, phenyl, substituted phenyl or phenyl-loweralkyl group and R3 and R4 each represent a hydrogen atom or a loweralkyl, phenyl or phenyl-loweralkyl group wherein phenyl is optionally substituted, or R3 and R4 taken with the adjacent nitrogen form a heterocyclic residue.

  N-(芳硫基)-N'-(氨基烷基)脲类和硫脲类及氧化衍生物，其式为 其中 B 代表硫代、亚砜基或磺酰基；R1 和 R2 各代表一个氢原子或低级烷基、环烷基、2-呋喃基、苯基、取代苯基或苯基-低级烷基，R3 和 R4 各代表一个氢原子或低级烷基、苯基或苯基-低级烷基，其中苯基任选被取代，或 R3 和 R4 与相邻的氮形成杂环残基。
• Derivatives of alkylaminoalkyl ureas and cyanoguanidines
  申请人：A.H. ROBINS COMPANY, INCORPORATED

  公开号：EP0295010A1

  公开（公告）日：1988-12-14

  Compounds of general formula I wherein, Ar represents a 1-naphthyl group, a 2-naphthyl group, a 2,3-dihydro-1 H-inden-4(or 5)-yl group, a 2-furanylmethyl group, a 2-pyridinyl group, a phenyl group or a phenyl substituted by one to three substituents wherein the or each substituent independently represents a loweralkyl group, a loweralkoxy group, a diloweralkylamino group, a cyano group, a loweralkylthio group, a loweralkylsulfinyl group, a loweralkylsulfonyl group, an acyl group, an acylamino group, an aminocarbonyl group, a diloweral- kylaminoloweralkoxy group, a trifluoromethyl group, a nitro group or a halogen atom; X represents a thio group, a sulfinyl group, a sulfonyl group or an oxygen atom; d represents zero or one; B represents a carbonyl group, a thioxomethyl group or a cyanoiminomethyl group; each of n, m and p independently represents an integer from 2 to 6 inclusive; each of Z and W independently represent an R group or a group with the proviso that when Z represents R, W represents a -(CH2)m-NR1R2 group and when Z represents (CH2)m-NR1R2, W represents R; each of R, R1, R2, R3 and R4 independently represents a hydrogen atom, a loweralkyl group, a cycloalkyl group, a phenyl group or a phenylloweralkyl group wherein phenyl may be substituted by one to three radicals wherein each radical independently represents a loweralkyl group, a loweralkoxy group, a cyano group, a trifluoromethyl group, a nitro group or a halogen atom or each of R1 and R2, and R3 and R4 may, together with the adjacent nitrogen atom form the heterocyclic ring structure 1-homopiperidinyl, 1-piperidinyl, 4-morpholinyl, 1-pyrrolidinyl, 1-piperazinyl, or 4-substituted-1-piperazinyl; with the further proviso that some meanings given for the symbols must not be realized simultaneously, as indicated specifically in claim 1, or the pharmaceutically acceptable salts thereof are useful in the treatment of cardiac arrhythmia.

  通式 I 的化合物 其中 Ar 代表 1-萘基、2-萘基、2,3-二氢-1 H-茚-4（或 5）-基、2-呋喃甲基、2-吡啶基、苯基或被一至三个取代基取代的苯基，其中或每个取代基独立地代表低级烷基、一个低级烷氧基、一个低级烷氨基、一个氰基、一个低级烷硫基、一个低级烷基亚磺基、一个低级烷基磺酰基、一个酰基、一个酰氨基、一个氨基羰基、一个低级烷氨基低级烷氧基、一个三氟甲基、一个硝基或一个卤原子； X 代表硫代基团、亚砜基团、磺酰基团或氧原子； d 代表 0 或 1； B 代表羰基、硫氧甲基或氰亚氨基甲基； n、m 和 p 各自独立地代表 2 至 6（含 6）的整数 Z和W各自独立地代表一个R基团或一个 但当 Z 代表 R 时，W 代表-(CH2)m-NR1R2 基团；当 Z 代表 ( )m-NR1R2 时，W 代表 R； R、R1、R2、R3 和 R4 各自独立地代表氢原子、低级烷基、环烷基、苯基或苯基低级烷基，其中苯基可被一至三个基团取代，每个基团独立地代表低级烷基、低级烷氧基、氰基、三氟甲基、硝基或卤素原子或 R1 和 R2 以及 R3 和 R4 中的每一个可与相邻的氮原子一起形成杂环结构 1-高哌啶基、1-哌啶基、4-吗啉基、1-吡咯烷基、1-哌嗪基或 4-取代-1-哌嗪基； 进一步的但书是，如权利要求 1 中特别指出的，符号的某些含义不得同时实现，或其药学上可接受的盐类可用于治疗心律失常。
• PYRROLIDINE DERIVATIVES AS HISTAMINE H3 RECEPTOR ANTAGONISTS
  申请人：ELI LILLY AND COMPANY

  公开号：EP1861360A1

  公开（公告）日：2007-12-05